Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07085351 · ClinicalTrials.gov registry record
EEG Biomarkers for OUD: Diagnostic, Prognostic, and Predictive Applications
A clinical trial of Opiod Use Disorder, sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- 70
- Enrollment target
- 1
- Study location
NCT07085351 is a study of Opiod Use Disorder that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 70 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07085351, a study of Opiod Use Disorder, is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The US is suffering from a national opioid epidemic characterized by significant costs, overdoses, and deaths. Conventional Opioid Use Disorder (OUD) treatments (i.e., pharmacological and psychosocial interventions) are characterized by limited or diminishing efficacy, ceiling effects, and/or serious side effects. The availability of validated OUD biomarkers would be a key step in the development and approval of better treatments. Ultimately, the scarcity of OUD biomarkers represents a significant unmet need in the fight against opioid addiction as recognized by NIDA and the FDA with their support for development of Medical Device Development Tools (MDDT) and biomarker tests for OUD. Advances in neuroimaging techniques, and in particular recent evidence supports electroencephalography (EEG) as a promising candidate to investigate the correlation between addiction and brain state. To address the clear medical and market need for OUD biomarkers, this is a feasibility study to identify and assess potential EEG biomarkers for OUD diagnoses, disease monitoring, and prediction of OUD treatment response.
Conditions Studied
Study Locations (1)
Illinois
- Clinical & Imaging Research Outcomes Lab - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2025-02-04 |
| Est. Completion | 2025-09-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07085351
The ClinicalTrials.gov registry entry for NCT07085351 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Opiod Use Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT07085351 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT07085351 about?
NCT07085351 is a clinical study titled "EEG Biomarkers for OUD: Diagnostic, Prognostic, and Predictive Applications". The US is suffering from a national opioid epidemic characterized by significant costs, overdoses, and deaths. Conventional Opioid Use Disorder (OUD) treatments (i.e., pharmacological and psychosocial interventions) are characterized by limited or diminishing efficacy, ceiling effects, and/or seriou...
What is the current status of trial NCT07085351?
This trial is currently recruiting. The enrollment target is 70 participants. The study started on 2025-02-04. Estimated completion is 2025-09-15.
What conditions does trial NCT07085351 study?
This clinical trial studies the following conditions: Opiod Use Disorder.
Who is sponsoring clinical trial NCT07085351?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07085351 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opiod Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.